FI49159C - Förfarande för framställning av 9alfa-halogen-6alfa,16alfa-dimetyl-1,4 -pregnadien-3,20-dion-derivat. - Google Patents

Förfarande för framställning av 9alfa-halogen-6alfa,16alfa-dimetyl-1,4 -pregnadien-3,20-dion-derivat.

Info

Publication number
FI49159C
FI49159C FI712747A FI274771A FI49159C FI 49159 C FI49159 C FI 49159C FI 712747 A FI712747 A FI 712747A FI 274771 A FI274771 A FI 274771A FI 49159 C FI49159 C FI 49159C
Authority
FI
Finland
Prior art keywords
9alpha
6alpha
16alpha
pregnadiene
dimethyl
Prior art date
Application number
FI712747A
Other languages
English (en)
Finnish (fi)
Other versions
FI49159B (sv
Inventor
Klaus Kieslich
Ulrich Kerb
Klaus Mengel
Amadeo Domenico
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI49159B publication Critical patent/FI49159B/fi
Application granted granted Critical
Publication of FI49159C publication Critical patent/FI49159C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI712747A 1970-11-28 1971-10-01 Förfarande för framställning av 9alfa-halogen-6alfa,16alfa-dimetyl-1,4 -pregnadien-3,20-dion-derivat. FI49159C (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2059310A DE2059310C3 (de) 1970-11-28 1970-11-28 diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FI49159B FI49159B (sv) 1974-12-31
FI49159C true FI49159C (sv) 1975-04-10

Family

ID=5789778

Family Applications (1)

Application Number Title Priority Date Filing Date
FI712747A FI49159C (sv) 1970-11-28 1971-10-01 Förfarande för framställning av 9alfa-halogen-6alfa,16alfa-dimetyl-1,4 -pregnadien-3,20-dion-derivat.

Country Status (23)

Country Link
US (1) US3828083A (sv)
AR (1) AR193053A1 (sv)
AT (1) AT312824B (sv)
AU (1) AU3598871A (sv)
BE (1) BE775901A (sv)
CA (1) CA933915A (sv)
CH (2) CH591518A5 (sv)
CS (1) CS166787B2 (sv)
DE (1) DE2059310C3 (sv)
DK (1) DK135131C (sv)
EG (1) EG10261A (sv)
ES (1) ES395740A1 (sv)
FI (1) FI49159C (sv)
FR (1) FR2115437B1 (sv)
GB (1) GB1377993A (sv)
HU (1) HU162900B (sv)
IE (1) IE35822B1 (sv)
IL (1) IL38241A (sv)
NL (1) NL7116335A (sv)
RO (1) RO67639A (sv)
SE (1) SE374109B (sv)
SU (1) SU474141A3 (sv)
ZA (1) ZA717489B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448662C2 (de) * 1974-10-09 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
WO2011127048A2 (en) * 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE

Also Published As

Publication number Publication date
CA933915A (en) 1973-09-18
FI49159B (sv) 1974-12-31
SE374109B (sv) 1975-02-24
RO67639A (ro) 1982-10-26
IL38241A (en) 1975-08-31
AT312824B (de) 1974-01-25
DE2059310B2 (de) 1980-03-06
CS166787B2 (sv) 1976-03-29
NL7116335A (sv) 1972-05-30
SU440831A3 (sv) 1974-08-25
FR2115437A1 (sv) 1972-07-07
ZA717489B (en) 1972-07-26
ES395740A1 (es) 1973-12-01
EG10261A (en) 1976-04-30
IL38241A0 (en) 1972-01-27
AR193053A1 (es) 1973-03-30
PL74335B1 (sv) 1974-10-30
HU162900B (sv) 1973-04-28
FR2115437B1 (sv) 1975-04-18
DK135131C (da) 1977-08-08
IE35822B1 (en) 1976-05-26
CH617709A5 (sv) 1980-06-13
AU3598871A (en) 1973-05-31
IE35822L (en) 1972-05-28
BE775901A (fr) 1972-03-16
SU474141A3 (ru) 1975-06-14
CH591518A5 (sv) 1977-09-30
GB1377993A (en) 1974-12-18
DE2059310A1 (de) 1972-06-08
US3828083A (en) 1974-08-06
DE2059310C3 (de) 1980-10-30
DK135131B (da) 1977-03-07

Similar Documents

Publication Publication Date Title
FI47572C (sv) Förfarande för framställning av 19-norandrost-4-en-3,17-dioner.
FI47575C (sv) Analogiförfarande för framställning av evomonosid-derivat.
DK136218B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxysteroider af pregnan- eller 19-norpregnanrækken.
FI52216C (sv) Förfarande för framställning av gamma-piperidinobutyrofenonderivat.
DK128895B (da) Fremgangsmåde til fremstilling af pregnanderivater.
FI46619C (sv) Förfarande för framställning av 17alfa,21-ortokarbonater av steroidder ivat.
FI49160C (sv) Förfarande för framställning av 6alfa-fluor-16alfa,18-dimetyl-1,4-preg nadien-3,20-dionderivat.
DK130957B (da) Fremgangsmåde til fremstilling af pregnanderivater.
FI49159C (sv) Förfarande för framställning av 9alfa-halogen-6alfa,16alfa-dimetyl-1,4 -pregnadien-3,20-dion-derivat.
DK131296B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-19-nor-5alfa-pregnan-11,20-dion.
FI46952C (sv) Förfarande för framställning av 6alfa-fluor-9alfa,11beta,21-trihalogen -1,4-pregnadien-3,20-dion-derivat
FI52577C (sv) Förfarande för framställning av terapeutiskt användbara fenazinderivat .
FI46845C (sv) Förfarande för framställning av 6alfa-fluor-21-halogen-11beta-hydroxi- 16alfa-metyl-1,4-pregnadien-3,20-dion-derivat.
FI49029C (sv) Förfarande för framställning av 15alfa,16alfa-metylenandrostenderivat
FI48347C (sv) Förfarande för framställning av 17beta-alkanoyloxi-17alfa-propadienyl- steroider.
FI46727C (sv) Förfarande för framställning av pyridazolderivat.
FI48729C (sv) Förfarande för framställning av 3-cyklopentyloxi-7alfa-metyl-16alfa,17 -dihydroxi 1,3,5(10)-estratriener med hög estrogen aktivitet.
FI47352C (sv) Förfarande för framställning av antiinflammatoriska 6alfa-fluor-2-klor -16alfa-metyl-1,4-pregnadien-3,20-dionderivat.
DK131786B (da) Fremgangsmåde til fremstilling af delta4-3-oxo-1alfa-methylsteroider.
FI52088C (sv) Förfarande för framställning av 3-(4-acyloxialkyl-1-piperazinyl)-karbo nylmetyl-2-bensotiazolinonderivat.
FI47481C (sv) Analogiförfarande för framställning av nya anti-inflammatoriskt och ge stagent verksamma 21-fluor-6-halogen-16,17-dihydroxi-pregna-4,6-dien-3 ,20-dionderivat.
DK132121B (da) Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion.
DK128208B (da) Fremgangsmåde til fremstilling af 1,4-diensteroider af androstan- eller pregnanrækken med usubstitueret 3-stilling.
FI47094C (sv) Förfarande för framställning av steroid-spirocyklobutanoner.
DK129040B (da) Fremgangsmåde til fremstilling af 9α-chlor-11β-hydroxysteroider af pregnanrækken.